This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1r1x
From Proteopedia
(New page: 200px<br /> <applet load="1r1x" size="450" color="white" frame="true" align="right" spinBox="true" caption="1r1x, resolution 2.15Å" /> '''Crystal structure o...) |
|||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Hemoglobin (Hb) Bassett, an abnormal Hb variant with a markedly reduced, oxygen affinity, was discovered in a Caucasian (Anglo-Saxon) male child, who experienced episodes of cyanosis. Cation-exchange and reversed-phase, (RP) high-performance liquid chromatography (HPLC) showed that the patient, has an abnormal Hb, with a mutation in the alpha-globin. Tryptic peptide, digest of the abnormal alpha-globin with subsequent HPLC analysis revealed, abnormal elution of the alpha-T11 peptide. Further studies with Edman, sequencing and electrospray mass spectrometry of tryptic peptide, alpha-T11, as well as structural analysis by X-ray crystallography, revealed an Asp-->Ala substitution at the alpha94 (G1) position, a match, for Hb Bassett. Detailed functional studies showed that this Hb variant, had a markedly reduced oxygen affinity (P(50) at pH 7.0 = 22 mmHg; Hb A, P(50) = 10.5 mmHg), reduced Bohr effect (-0.26 compared to - 0.54 in Hb, A), and low subunit cooperativity (n = 1.4, compared to 2.6 in Hb A)., X-ray crystallography results explain the probable effects of the, structural modification on the oxygen-binding properties of this Hb, variant. | Hemoglobin (Hb) Bassett, an abnormal Hb variant with a markedly reduced, oxygen affinity, was discovered in a Caucasian (Anglo-Saxon) male child, who experienced episodes of cyanosis. Cation-exchange and reversed-phase, (RP) high-performance liquid chromatography (HPLC) showed that the patient, has an abnormal Hb, with a mutation in the alpha-globin. Tryptic peptide, digest of the abnormal alpha-globin with subsequent HPLC analysis revealed, abnormal elution of the alpha-T11 peptide. Further studies with Edman, sequencing and electrospray mass spectrometry of tryptic peptide, alpha-T11, as well as structural analysis by X-ray crystallography, revealed an Asp-->Ala substitution at the alpha94 (G1) position, a match, for Hb Bassett. Detailed functional studies showed that this Hb variant, had a markedly reduced oxygen affinity (P(50) at pH 7.0 = 22 mmHg; Hb A, P(50) = 10.5 mmHg), reduced Bohr effect (-0.26 compared to - 0.54 in Hb, A), and low subunit cooperativity (n = 1.4, compared to 2.6 in Hb A)., X-ray crystallography results explain the probable effects of the, structural modification on the oxygen-binding properties of this Hb, variant. | ||
| + | |||
| + | ==Disease== | ||
| + | Known diseases associated with this structure: Erythremias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Erythremias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Erythrocytosis OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], HPFH, deletion type OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Heinz body anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Heinz body anemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Heinz body anemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Hemoglobin H disease OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Hypochromic microcytic anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Methemoglobinemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Methemoglobinemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Sickle cell anemia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Thalassemia, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141850 141850]], Thalassemia-beta, dominant inclusion-body OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]], Thalassemias, alpha- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141800 141800]], Thalassemias, beta- OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=141900 141900]] | ||
==About this Structure== | ==About this Structure== | ||
| Line 31: | Line 34: | ||
[[Category: rochester]] | [[Category: rochester]] | ||
| - | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:58:36 2007'' |
Revision as of 16:52, 12 November 2007
|
Crystal structure of oxy-human hemoglobin Bassett at 2.15 angstrom
Contents |
Overview
Hemoglobin (Hb) Bassett, an abnormal Hb variant with a markedly reduced, oxygen affinity, was discovered in a Caucasian (Anglo-Saxon) male child, who experienced episodes of cyanosis. Cation-exchange and reversed-phase, (RP) high-performance liquid chromatography (HPLC) showed that the patient, has an abnormal Hb, with a mutation in the alpha-globin. Tryptic peptide, digest of the abnormal alpha-globin with subsequent HPLC analysis revealed, abnormal elution of the alpha-T11 peptide. Further studies with Edman, sequencing and electrospray mass spectrometry of tryptic peptide, alpha-T11, as well as structural analysis by X-ray crystallography, revealed an Asp-->Ala substitution at the alpha94 (G1) position, a match, for Hb Bassett. Detailed functional studies showed that this Hb variant, had a markedly reduced oxygen affinity (P(50) at pH 7.0 = 22 mmHg; Hb A, P(50) = 10.5 mmHg), reduced Bohr effect (-0.26 compared to - 0.54 in Hb, A), and low subunit cooperativity (n = 1.4, compared to 2.6 in Hb A)., X-ray crystallography results explain the probable effects of the, structural modification on the oxygen-binding properties of this Hb, variant.
Disease
Known diseases associated with this structure: Erythremias, alpha- OMIM:[141800], Erythremias, beta- OMIM:[141900], Erythrocytosis OMIM:[141850], HPFH, deletion type OMIM:[141900], Heinz body anemia OMIM:[141850], Heinz body anemias, alpha- OMIM:[141800], Heinz body anemias, beta- OMIM:[141900], Hemoglobin H disease OMIM:[141850], Hypochromic microcytic anemia OMIM:[141850], Methemoglobinemias, alpha- OMIM:[141800], Methemoglobinemias, beta- OMIM:[141900], Sickle cell anemia OMIM:[141900], Thalassemia, alpha- OMIM:[141850], Thalassemia-beta, dominant inclusion-body OMIM:[141900], Thalassemias, alpha- OMIM:[141800], Thalassemias, beta- OMIM:[141900]
About this Structure
1R1X is a Protein complex structure of sequences from Homo sapiens with CMO, HEM and MBN as ligands. Full crystallographic information is available from OCA.
Reference
Characterization of hemoglobin bassett (alpha94Asp-->Ala), a variant with very low oxygen affinity., Abdulmalik O, Safo MK, Lerner NB, Ochotorena J, Daikhin E, Lakka V, Santacroce R, Abraham DJ, Asakura T, Am J Hematol. 2004 Nov;77(3):268-76. PMID:15495251
Page seeded by OCA on Mon Nov 12 18:58:36 2007
Categories: Homo sapiens | Protein complex | Abdulmalik, O. | Abraham, D.J. | Asakura, T. | Dhaikin, Y. | Lerner, N.B. | Ochotorena, J. | Safo, M.K. | CMO | HEM | MBN | Carbon monoxide | Crystal structure | Hemoglobin | Mutant | Oxygen affinity | Rochester
